| 6 | In silico identification of public neo-antigens in head and neck Cancer for T cell receptor Engineering: Targeting PI3KCA and TP53 missense mutations. (Zenga J, Himburg HA, Wong SJ, Kearl T, Hematti P, Jin VX, Memon AA, Mathison AJ, Awan MJ) Oral Oncol 2024 Sep;156:106947 |
| 1 | Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy. (Shah RK, Cygan E, Kozlik T, Colina A, Zamora AE) Front Immunol 2023;14:1301100 1 Citation |
| 1 | Cationic micelle delivery of a multi-epitope vaccine candidate derived from tumor-associated antigens, causing regression in established CT26 colorectal tumors in mice. (Sabzehei F, Taromchi AH, Ramazani A, Nedaei K, Feizi A, Arsang-Jang S, Danafar H) J Biomed Mater Res A 2024 May;112(5):733-742 2 Citations |
| 1 | TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma. (Schaettler MO, Desai R, Wang AZ, Livingstone AJ, Kobayashi DK, Coxon AT, Bowman-Kirigin JA, Liu CJ, Li M, Bender DE, White MJ, Kranz DM, Johanns TM, Dunn GP) J Immunother Cancer 2023 Feb;11(2) 6 Citations |
| 1 | The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain. (Bowman-Kirigin JA, Desai R, Saunders BT, Wang AZ, Schaettler MO, Liu CJ, Livingstone AJ, Kobayashi DK, Durai V, Kretzer NM, Zipfel GJ, Leuthardt EC, Osbun JW, Chicoine MR, Kim AH, Murphy KM, Johanns TM, Zinselmeyer BH, Dunn GP) Cancer Immunol Res 2023 Jan 03;11(1):20-37 16 Citations |
| 1 | Antigen cross-presentation in young tumor-bearing hosts promotes CD8+ T cell terminal differentiation. (Moustaki A, Crawford JC, Alli S, Fan Y, Boi S, Zamora AE, McDonald NMN, Wu G, Nakitandwe J, Newman S, Foy S, Silkov A, Thomas PG, Pappo A, Dyer MA, Stewart E, Federico S, Youngblood B) Sci Immunol 2022 Feb 04;7(68):eabf6136 10 Citations |
| 1 | Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL. (Zhao Y, Aldoss I, Qu C, Crawford JC, Gu Z, Allen EK, Zamora AE, Alexander TB, Wang J, Goto H, Imamura T, Akahane K, Marcucci G, Stein AS, Bhatia R, Thomas PG, Forman SJ, Mullighan CG, Roberts KG) Blood 2021 Jan 28;137(4):471-484 92 Citations |
| 1 | A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma. (Bartlett NL, Herrera AF, Domingo-Domenech E, Mehta A, Forero-Torres A, Garcia-Sanz R, Armand P, Devata S, Izquierdo AR, Lossos IS, Reeder C, Sher T, Chen R, Schwarz SE, Alland L, Strassz A, Prier K, Choe-Juliak C, Ansell SM) Blood 2020 Nov 19;136(21):2401-2409 114 Citations |
| 1 | Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy. (Pham TV, Boichard A, Goodman A, Riviere P, Yeerna H, Tamayo P, Kurzrock R) Mol Oncol 2020 Aug;14(8):1680-1694 36 Citations |
| 1 | MHC-I genotype and tumor mutational burden predict response to immunotherapy. (Goodman AM, Castro A, Pyke RM, Okamura R, Kato S, Riviere P, Frampton G, Sokol E, Zhang X, Ball ED, Carter H, Kurzrock R) Genome Med 2020 May 19;12(1):45 84 Citations |
| 1 | Stereotactic body radiation therapy and immunotherapy. (Khalife M, Shahid K, Dabney RS, Phan AT) Clin Adv Hematol Oncol 2019 Sep;17(9):518-523 4 Citations |
| 1 | In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab. (Atanackovic D, Yousef S, Shorter C, Tantravahi SK, Steinbach M, Iglesias F, Sborov D, Radhakrishnan SV, Chiron M, Miles R, Salama M, Kröger N, Luetkens T) Leukemia 2020 Jan;34(1):317-321 30 Citations |
| 1 | Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8+ T cell responses. (Zamora AE, Crawford JC, Allen EK, Guo XJ, Bakke J, Carter RA, Abdelsamed HA, Moustaki A, Li Y, Chang TC, Awad W, Dallas MH, Mullighan CG, Downing JR, Geiger TL, Chen T, Green DR, Youngblood BA, Zhang J, Thomas PG) Sci Transl Med 2019 Jun 26;11(498) 68 Citations |
| 1 | Clinical and Immunological Implications of Frameshift Mutations in Lung Cancer. (Chae YK, Viveiros P, Lopes G, Sukhadia B, Sheikh MM, Saravia D, Florou V, Sokol ES, Frampton GM, Chalmers ZR, Ali SM, Ross JS, Chang S, Wang S, Chiec L, Rahbari A, Mohindra N, Villaflor V, Shin SH, Oh M, Anker J, Park LC, Wang V, Chuang J, Park W) J Thorac Oncol 2019 Oct;14(10):1807-1817 35 Citations |
| 1 | Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer. (Adashek JJ, Junior PNA, Galanina N, Kurzrock R) J Immunother Cancer 2019 May 22;7(1):130 7 Citations |
| 1 | Modelling CAR-T therapy in humanized mice. (Wu Y, Yu XZ) EBioMedicine 2019 Feb;40:25-26 10 Citations |
| 1 | Hitting the Target: How T Cells Detect and Eliminate Tumors. (Zamora AE, Crawford JC, Thomas PG) J Immunol 2018 Jan 15;200(2):392-399 77 Citations |
| 1 | Rapid Loss of RNA Detection by In Situ Hybridization in Stored Tissue Blocks and Preservation by Cold Storage of Unstained Slides. (Baena-Del Valle JA, Zheng Q, Hicks JL, Fedor H, Trock BJ, Morrissey C, Corey E, Cornish TC, Sfanos KS, De Marzo AM) Am J Clin Pathol 2017 Nov 02;148(5):398-415 52 Citations |
| 1 | Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients. (Heestand GM, Schwaederle M, Gatalica Z, Arguello D, Kurzrock R) Eur J Cancer 2017 Sep;83:80-87 57 Citations |
| 1 | EGFR-Dependent Regulated Intramembrane Proteolysis of EpCAM-Response. (Hsu YT, Osmulski P, Wang Y, Huang YW, Liu L, Ruan J, Jin VX, Kirma NB, Gaczynska ME, Huang TH) Cancer Res 2017 Apr 01;77(7):1777 3 Citations |
| 1 | Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma. (Moy JD, Moskovitz JM, Ferris RL) Eur J Cancer 2017 May;76:152-166 84 Citations |
| 1 | T-cell programming in pancreatic adenocarcinoma: a review. (Seo YD, Pillarisetty VG) Cancer Gene Ther 2017 Mar;24(3):106-113 42 Citations |
| 1 | Emerging immunotherapies for glioblastoma. (Desai R, Suryadevara CM, Batich KA, Farber SH, Sanchez-Perez L, Sampson JH) Expert Opin Emerg Drugs 2016 Jun;21(2):133-45 37 Citations |
| 1 | A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer. (Jagadish N, Parashar D, Gupta N, Agarwal S, Purohit S, Kumar V, Sharma A, Fatima R, Topno AP, Shaha C, Suri A) J Exp Clin Cancer Res 2015 Nov 21;34:142 42 Citations |
| 2 | IL17 Functions through the Novel REG3β-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic Cancer. (Loncle C, Bonjoch L, Folch-Puy E, Lopez-Millan MB, Lac S, Molejon MI, Chuluyan E, Cordelier P, Dubus P, Lomberk G, Urrutia R, Closa D, Iovanna JL) Cancer Res 2015 Nov 15;75(22):4852-62 98 Citations |
| 1 | The effects of CAMPATH-1H on cell viability do not correlate to the CD52 density on the cell surface. (Lee F, Luevano M, Veys P, Yong K, Madrigal A, Shaw BE, Saudemont A) PLoS One 2014;9(7):e103254 8 Citations |
| 4 | Molecular profiling in gastric cancer: examining potential targets for chemotherapy. (Miura JT, Johnston FM, Thomas J, George B, Eastwood D, Tsai S, Christians KK, Turaga KK, Gamblin TC) J Surg Oncol 2014 Sep;110(3):302-6 9 Citations |
| 1 | Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways. (Wang JC, Felizardo TC, Au BC, Fowler DH, Dekaban GA, Medin JA) Virol J 2013 Jul 20;10:240 9 Citations |
| 1 | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. (Fogeron ML, Müller H, Schade S, Dreher F, Lehmann V, Kühnel A, Scholz AK, Kashofer K, Zerck A, Fauler B, Lurz R, Herwig R, Zatloukal K, Lehrach H, Gobom J, Nordhoff E, Lange BM) Nat Commun 2013;4:1531 59 Citations |
| 1 | COPI transport complexes bind to specific RNAs in neuronal cells. (Todd AG, Lin H, Ebert AD, Liu Y, Androphy EJ) Hum Mol Genet 2013 Feb 15;22(4):729-36 41 Citations |
| 1 | Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients. (Clark RA, Watanabe R, Teague JE, Schlapbach C, Tawa MC, Adams N, Dorosario AA, Chaney KS, Cutler CS, Leboeuf NR, Carter JB, Fisher DC, Kupper TS) Sci Transl Med 2012 Jan 18;4(117):117ra7 300 Citations |
| 1 | Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a-/- mutants. (Sapetto-Rebow B, McLoughlin SC, O'Shea LC, O'Leary O, Willer JR, Alvarez Y, Collery R, O'Sullivan J, Van Eeden F, Hensey C, Kennedy BN) BMC Dev Biol 2011 Nov 23;11:71 16 Citations |
| 1 | Phosphorylation and stabilization of topoisomerase IIα protein by p38γ mitogen-activated protein kinase sensitize breast cancer cells to its poisons. (Qi X, Hou S, Lepp A, Li R, Basir Z, Lou Z, Chen G) J Biol Chem 2011 Oct 14;286(41):35883-35890 25 Citations |
| 1 | MAGE I transcription factors regulate KAP1 and KRAB domain zinc finger transcription factor mediated gene repression. (Xiao TZ, Bhatia N, Urrutia R, Lomberk GA, Simpson A, Longley BJ) PLoS One 2011;6(8):e23747 40 Citations |
| 3 | CD200 expression in plasma cell myeloma. (Olteanu H, Harrington AM, Hari P, Kroft SH) Br J Haematol 2011 May;153(3):408-11 36 Citations |
| 1 | Tumor antigen analysis in neuroblastoma by serological interrogation of bioinformatic data. (Kohler ME, Johnson BD, Palen K, Chen QR, Khan J, Orentas RJ) Cancer Sci 2010 Nov;101(11):2316-24 6 Citations |
| 1 | Rituximab in chronic lymphocytic leukemia. (Jaglowski SM, Byrd JC) Semin Hematol 2010 Apr;47(2):156-69 31 Citations |
| 1 | CD23 expression in plasma cell myeloma is specific for abnormalities of chromosome 11, and is associated with primary plasma cell leukaemia in this cytogenetic sub-group. (Walters M, Olteanu H, Van Tuinen P, Kroft SH) Br J Haematol 2010 Apr;149(2):292-3 24 Citations |
| 1 | Targeted glycoproteomic identification of biomarkers for human breast carcinoma. (Abbott KL, Aoki K, Lim JM, Porterfield M, Johnson R, O'Regan RM, Wells L, Tiemeyer M, Pierce M) J Proteome Res 2008 Apr;7(4):1470-80 88 Citations |
| 1 | Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. (Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED) J Clin Oncol 2007 Oct 20;25(30):4757-64 164 Citations |
| 1 | Serum from mice immunized in the context of Treg inhibition identifies DEK as a neuroblastoma tumor antigen. (Zheng J, Kohler ME, Chen Q, Weber J, Khan J, Johnson BD, Orentas RJ) BMC Immunol 2007 Mar 30;8:4 11 Citations |
| 1 | Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials. (Mossoba ME, Medin JA) Expert Rev Vaccines 2006 Oct;5(5):717-32 24 Citations |
| 1 | Pulmonary alveolar proteinosis. (Ioachimescu OC, Kavuru MS) Chron Respir Dis 2006;3(3):149-59 82 Citations |
| 1 | CD5-positive B-cell neoplasms of indeterminate immunophenotype: a clinicopathologic analysis of 26 cases. (Asplund SL, McKenna RW, Doolittle JE, Kroft SH) Appl Immunohistochem Mol Morphol 2005 Dec;13(4):311-7 16 Citations |
| 1 | The effect of nonoxynol-9 on human endometrium. (Jain JK, Li A, Minoo P, Nucatola DL, Felix JC) Contraception 2005 Feb;71(2):137-42 24 Citations |
| 1 | Expression and localization of GRP75 in human epithelial tumors and normal tissues. (Srokowski T, Pfeifer JD, Li J, Olson LM, Rader JS) Appl Immunohistochem Mol Morphol 2004 Jun;12(2):132-8 7 Citations |
| 1 | Survivin expression in juvenile-onset recurrent respiratory papillomatosis. (Poetker DM, Sandler AD, Scott DL, Smith RJ, Bauman NM) Ann Otol Rhinol Laryngol 2002 Nov;111(11):957-61 17 Citations |
| 1 | Comparison of immunophenotypes of small B-cell neoplasms in primary lymph node and concurrent blood or marrow samples. (Xu Y, McKenna RW, Asplund SL, Kroft SH) Am J Clin Pathol 2002 Nov;118(5):758-64 21 Citations |
| 1 | De novo CD5+ diffuse large B-cell lymphomas. A heterogeneous group containing an unusual form of splenic lymphoma. (Kroft SH, Howard MS, Picker LJ, Ansari MQ, Aquino DB, McKenna RW) Am J Clin Pathol 2000 Oct;114(4):523-33 48 Citations |
| 1 | Specific targeting of EGP-2+ tumor cells by primary lymphocytes modified with chimeric T cell receptors. (Ren-Heidenreich L, Hayman GT, Trevor KT) Hum Gene Ther 2000 Jan 01;11(1):9-19 36 Citations |
| 1 | Induction of immune responses to ovarian tumor antigens by multiparity. (Shields LB, Gerçel-Taylor C, Yashar CM, Wan TC, Katsanis WA, Spinnato JA, Taylor DD) J Soc Gynecol Investig 1997;4(6):298-304 70 Citations |
| 1 | Tumor antigens in astrocytic gliomas. (Kurpad SN, Zhao XG, Wikstrand CJ, Batra SK, McLendon RE, Bigner DD) Glia 1995 Nov;15(3):244-56 107 Citations |
| 1 | Immunobiology of malignant astrocytomas. (Kurpad SN, Wikstrand CJ, Bigner DD) Semin Oncol 1994 Apr;21(2):149-61 21 Citations |
| 1 | Distribution of Lyb-4.1 and other membrane antigens on murine lymphoid tumors. (Howe RC, Nelson RS, Rogan KM, Ahmed A, Aiken JJ, Dorf ME, Scherer JC, Sell KW, Humphreys RE) J Natl Cancer Inst 1979 Aug;63(2):375-8 2 Citations |
| 1 | Heterogeneity in the membrane proteins of human lymphoid cell lines as seen in sodium dodecyl sulfate-polyacrylamide electrophoresis slab gels. (Rogan KM, Faldetta TJ, Boto W, Aiken JJ, DeMartino JL, Howe RC, Spiro RC, Humphreys RE) Cancer Res 1978 Nov;38(11 Pt 1):3604-10 12 Citations |
